PharmaSource Podcast

Agentic AI x Pharma Manufacturing: Interview with Matt Lowe, Chief Strategy Officer, MasterControl

26 Apr 2026

Contributed by Lukas

"If I have one more person talk to me about agentic AI and then realize they're still using paper batch records, I'm going to scream.&quo...

Oral Solid Dosage Manufacturing: Inside Rottendorf Pharma’s Strategic Alliance With Corealis Pharma

23 Apr 2026

Contributed by Lukas

“Aligning development strategy early creates a real competitive advantage. When scalability and late-stage requirements are already considered durin...

Combination Product Manufacturing: GLP-1 Hype, Talent Shortages, and the CDMO Shift

20 Apr 2026

Contributed by Lukas

“Capacity isn’t the biggest gap. It’s people. And nobody’s talking about it.”For pharma and biotech companies, manufacturing combination dev...

Novartis on What Great CDMO Partnerships Actually Look Like

16 Apr 2026

Contributed by Lukas

“Don’t pick a CMO that just agrees with you.”Isabel Feuerstein is Head of Business Development for EU and Asia CMO at Novartis, where she shapes...

Eramol's Sterile Facility Targets >1% Material Loss for Biotech Clients

13 Apr 2026

Contributed by Lukas

"Every milliliter lost translates to delayed timelines and increased costs."For early-phase biotech companies working with limited API batch...

Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever

09 Apr 2026

Contributed by Lukas

“One day lost during a clinical phase is one day of peak sales that is lost — always.”Nicolas Ragot, Chief Executive Officer of Delpharm, brings...

The Pharma Direct-to-Consumer Shift: Moving Faster Than Infrastructure Can Handle

06 Apr 2026

Contributed by Lukas

“We’re witnessing what I would consider the most structurally disruptive pharmaceutical moment I’ve seen in my career—and it’s being driven ...

How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform

02 Apr 2026

Contributed by Lukas

"Sponsors don't want to know how many SOPs you have on the shelf. They're really looking to see if you have sound judgment to take care o...

Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever

02 Apr 2026

Contributed by Lukas

“One day lost during a clinical phase is one day of peak sales that is lost — always.”Nicolas Ragot, Chief Executive Officer of Delpharm, brings...

Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models

30 Mar 2026

Contributed by Lukas

“The level of comfort with AI use in this space is pretty low right now.” Mike Boyson’s observation cuts to the heart of pharma’s AI dilemma. ...

Hybrid Synthesis is Redefining Peptide Manufacturing

26 Mar 2026

Contributed by Lukas

“Drug candidates that previously would not have been considered feasible — they’re now on the table. Hybrid synthesis is opening the door to pep...

The Case for Strategic CDMO Partnerships Over Multi-Sourcing

23 Mar 2026

Contributed by Lukas

“Our on-time-in-full delivery was 30%. In the beer industry, it’s around 99%. That was a big shock.”When Gijs Vissers joined the pharmaceutical ...

CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO

16 Mar 2026

Contributed by Lukas

“CDMOs and Biotechs will both die,” warns NKILT Therapeutics CEO as he talks candidly about the funding crisis stalling cell therapy development, ...

Trump's Most-Favored-Nation Policy Is Forcing Europe's Pharma Industry to Reconsider Its Pricing Strategy

09 Mar 2026

Contributed by Lukas

"A high-level Pfizer manager went on record and said: if they had to choose between lowering prices in the US or not launching in France — they...

How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains

05 Mar 2026

Contributed by Lukas

“The wake-up call happened during COVID — we realized our dependency on basic medicines coming from outside Europe was dangerously high.”Elisabe...

Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy

02 Mar 2026

Contributed by Lukas

“83% of the top 100 most prescribed generic medicines in the US have no domestic manufacturing source for their API.” — Charles Lyon, VP Manufa...

How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO

26 Feb 2026

Contributed by Lukas

“Managing a radiopharmaceutical supply chain is like transporting a block of ice in the middle of summer under the scorching sun in the desert—you...

U.S. Vaccine Policy Shifts are Create a “Chilling” Effect on Global Manufacturing and Innovation

23 Feb 2026

Contributed by Lukas

“If you take away funding from research and development, especially for diseases with pandemic potential, those programs will be delayed. We lose ti...

Why Pharma Contract Negotiations Are Flawed and How to Fix Them

16 Feb 2026

Contributed by Lukas

Picture the scene: the Sales teams from a CDMO and Sponsor are delighted to have finalized the principles of a manufacturing deal, the relationship is...

How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai

10 Feb 2026

Contributed by Lukas

“Intrinsically, there is nothing wrong with using Chinese CDMOs. But because of geopolitical issues, some large pharma want to have redundancy of th...

Digital Transparency Platform to be Launched by SGS CDMO Solutions

09 Feb 2026

Contributed by Lukas

By 2028, SGS CDMO Solutions’ MHRA and FDA-inspected site in Wales will operate entirely without paper. For biotech and Pharmaceutical sponsors, this...

2026 US Pharma Outsourcing: Gil Roth on FDA Cuts, Pricing Pressures and CDMO Strategy

01 Feb 2026

Contributed by Lukas

FDA hemorrhaging staff while promising to fast-track advanced modalities. BIOSECURE Act signed into law with five-year phase-out timelines. Tariffs cr...

Reshoring Pressure vs. Manufacturing Reality: Report from ExM Leader Boston

26 Jan 2026

Contributed by Lukas

Fresh from External Manufacturing Leaders in snowy Boston, in this episode we are sharing insights from senior biopharma executives confronting an imp...

Why Radiopharma Must Compete on Service Excellence – Not Clinical Data

18 Jan 2026

Contributed by Lukas

“There are 437 active clinical trials in radiopharmaceuticals, and 100 companies developing them. If your logistics are not better, there is no othe...

Supply Chain Resilience Through Geographic Redundancy [Simtra BioPharma Solutions CEO]

12 Jan 2026

Contributed by Lukas

“We’re not trying to be everything for everyone. Our specialized focus has been very exciting for me.”Franco Negron, CEO of Simtra BioPharma So...

How Integrated Drug Development and Manufacturing Creates Speed Advantage in Contract Pharma

05 Jan 2026

Contributed by Lukas

“Process chemistry alone is no longer the whole story—it needs to be connected with engineering solutions, digital tools, and data utilization.”...

How Charles River Helps Sponsors Accelerate Drug Development Through Strategic Testing

29 Dec 2025

Contributed by Lukas

“Biotechs need flexibility and have limited budgets, while big pharma looks for long-term partnerships, reliability, scalability, and new technologi...

The Great Reshoring: US Captures 74% of CDMO Investment

22 Dec 2025

Contributed by Lukas

PharmaSource analysis of 732 industry announcements reveals massive investment in U.S. capacity, with partnerships dominating the news cycle and advan...

ADC Manufacturing Demand Outpaces Capacity in US Market

14 Dec 2025

Contributed by Lukas

“Twenty years ago, who knew that ADCs and next-generation bioconjugates were going to be so exciting, so successful?”Campbell Bunce, Chief Scienti...

Breaking the Death Spiral: How to Rescue Failing CDMO Relationships Before It’s Too Late

09 Dec 2025

Contributed by Lukas

“When I walked into the tech transfer, we were a million dollars over budget, six months behind schedule, and struggling to make a single successful...

Markus Sieger Reflects on 25 Years Building Polpharma into Europe’s Generic Manufacturing Leader

08 Dec 2025

Contributed by Lukas

“We have to be transparent down to the last person in the organization, what the organization is doing, and where the issues are. We have to celebra...

CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities

04 Dec 2025

Contributed by Lukas

“Our goal is to be recognized for exceptional reliability in our services and manufacturing, while helping our customers bring the most innovative m...

What BioPlan's 22-Year Data Reveals About the Future of Biopharmaceutical Outsourcing

01 Dec 2025

Contributed by Lukas

"If you can't demonstrate international quality standards, nobody is going to take a chance on a million-dollar batch to save a few dollars o...

How Piramal Pharma Built a $1 Billion CDMO by Solving Client Problems, Not Selling Services

26 Nov 2025

Contributed by Lukas

“The world can change overnight. We have to accept volatility as part of the world we live in.”Peter DeYoung, CEO of Piramal Global Pharma, has sp...

The End of Global Pharma Supply Chains: How Regionalization Will Impact Industry Profitability

23 Nov 2025

Contributed by Lukas

"We are not in a transient moment - this will affect industry profitability for decades. The previous era of rule-based international trade is go...

How KBI Biopharma’s “Analytical Powerhouse” Underpins Their Full-Service CDMO Growth

21 Nov 2025

Contributed by Lukas

“We became an analytical powerhouse before we started offering integrated process development and manufacturing. That’s what differentiates us.”...

Ardena CEO on Navigating CDMO Volatility: Specialization, Nanomedicine, and Resilience

19 Nov 2025

Contributed by Lukas

“Despite the volatility, the industry is getting some positive energy and renewed confidence”Jeremie Trochu, Chief Executive Officer at Ardena, h...

Biotech Funding Strategies for European Companies

17 Nov 2025

Contributed by Lukas

"Life has not become simpler and easier. It's become more complex. Success requires acknowledging this complexity early and building flexibil...

Poland's Biotech Sector: From Emerging Market to Strategic Partner

13 Nov 2025

Contributed by Lukas

“Poland is no longer an emerging market. It’s a partnering market.”Dr. Magdalena Kulczycka, founder of the Biotech Innovation Institute, is a mo...

How to Build True CDMOs-Biotech Partnerships

10 Nov 2025

Contributed by Lukas

“We invest emotionally and intellectually in their journey—when their product reaches patients, that’s our success too.”Janet Hoogstraate, CEO...

Inside Thermo Fisher’s Strategy for Analytical Services Growth

06 Nov 2025

Contributed by Lukas

“The differentiator in our business isn’t the equipment and the facility—it’s the scientists working with customers to create assays and solve...

How Basel Became Europe’s Dynamic Biotech “Super Cluster”

03 Nov 2025

Contributed by Lukas

“This cluster has such a long history—it’s about chemistry meeting innovation, trading roots, and an open mindset. That unique mix created somet...

Pharma Trends: A Commercial Perspective on Oncology, GLP-1 Expansion, and AI-Accelerated Development

30 Oct 2025

Contributed by Lukas

"It costs about $2.5 billion to bring a drug to the market, and only about 30% of those actually succeed or meet their commercial goals when they...

MSD External Manufacturing: How Technical Operations are Driving Digital Innovation

26 Oct 2025

Contributed by Lukas

“The key word is curiosity. That curiosity helps you to question and improve not only yourself, but also your processes, your systems, and how you i...

Italy’s Biotech Future: How New Initiatives Are Breaking Down Growth Barriers

22 Oct 2025

Contributed by Lukas

“We have strong scientific foundations and manufacturing excellence. Now we’re creating the ecosystem to help biotechs scale and compete globally,...

Building Investor-Ready CMC Programs: Marta Kijanka’s Strategic Framework for Early-Stage Biotechs

20 Oct 2025

Contributed by Lukas

“CDMOs are partners with deep, extensive technical expertise that can be leveraged strategically—not just a restaurant where you pick from a menu....

ADC Manufacturing: How Smart CDMO Selection Drives Speed, Safety, and Scale

15 Oct 2025

Contributed by Lukas

“The complexity is there’s an antibody component, linker-payloads with highly potent toxic agents that need high containment, and linking a biolog...

NLS Days and Sweden's Life Science Ecosystem: A Nordic Innovation Powerhouse Explained

12 Oct 2025

Contributed by Lukas

"Sweden has been ranked the European Union's innovation leader for the fifth or sixth year in a row, and we're second globally. We have 4...

Sterile Injectable Manufacturing Explained: The Hidden Complexities Costing Biotechs Millions

06 Oct 2025

Contributed by Lukas

Carole Delauney warns that sterile injectable manufacturing “is not just fill-finish”—a misconception that can cost biotech companies millions a...

Pharma Procurement: The Cross-Functional Framework That Prevents Project Failures

29 Sep 2025

Contributed by Lukas

“Siloed procurement is a big problem. We’ve recently worked with a client where a CDMO was selected simply because it could start two weeks before...

Kindeva CEO Explains UK Expansion Strategy for Low-GWP Propellant Manufacturing

26 Sep 2025

Contributed by Lukas

 "Outsourcing is about giving the things you don't excel at to someone who does them exceptionally well. That's what speeds development and delivery,...

Roche's Strategic Supplier Model: Achieving Win-Win Manufacturing Partnerships Through Risk Sharing and Co-Investment

22 Sep 2025

Contributed by Lukas

“A strategic partnerships is not a transactional relationship – it’s a partnership that should last. If we incentivise through co-investments an...

[Exclusive] Society of Professional Pharmaceutical Consultants Launches - Interview with Ray Sison

18 Sep 2025

Contributed by Lukas

“Pharma consulting right now is an overgrown patch of weeds. Everybody’s just doing their own thing. It’s the Wild West compared to what it coul...

CDMO Live Europe 2026: Building Europe's Premier BioPharma Outsourcing Platform

15 Sep 2025

Contributed by Lukas

In this episode Luke Bilton, Co-Founder of PharmaSource, shares a special announcement about CDMO Live Europe 2026 (May 19-21, Rotterdam World Trade C...

How Takeda Drives Quality Excellence Across External Manufacturing Networks

11 Sep 2025

Contributed by Lukas

“The idea is to get the information in real time. And for that, you would go and see what systems you have at hand, what system your CMO is using, a...

Three Ways to Transform Pharmaceutical Supply Chains Through Smart, Green Technology with Intelsius

04 Sep 2025

Contributed by Lukas

"Sustainability isn't just about doing the right thing. It's about making smarter, more cost effective decisions that are really building...

CMC Development: How Early Manufacturing Decisions Prevent Costly Development Delays

01 Sep 2025

Contributed by Lukas

Link to the CDMO News Analysis download:CDMO News Analysis Tracker“CMC topics are often taken a bit late in development. The biggest pitfall is not ...

Teva's Drug Development Pivot: Dr. Eric A. Hughes EVP, Global R&D and Chief Medical Officer

26 Aug 2025

Contributed by Lukas

“The greatest opportunity at Teva is our innovative pipeline. We’re really leaning in on our innovative pipeline as an integral part of our pivot ...

How Grünenthal Builds Strategic External Supply Relationships with Felipe Furiati

18 Aug 2025

Contributed by Lukas

“We need to strive to be an easy client. Being an easy client with clear goals and internal alignment is key for successful long-term relationships ...

BioRN Reports Surge in US Applications as Scientists Seek New Opportunities - Interview with Dr. Julia Schaft, Managing Director

11 Aug 2025

Contributed by Lukas

"We are seeing a doubling or tripling of applications from the United States. You can really feel that shift already. People have been offered jo...

RFK Jr. Cancels $500M in mRNA Vaccine Development: US Government Abandons Pandemic Platform

06 Aug 2025

Contributed by Lukas

HHS Secretary’s unprecedented move to terminate 22 federal mRNA contracts sends shockwaves through biotech sector and raises critical questions abou...

From Lab to Patient: How Tetraneuron's Gene Therapy Approach is Tackling Alzheimer's Disease

31 Jul 2025

Contributed by Lukas

"When you are seeing great results in your research lab, you think that everything has been done. But then when you try to humanise your drug, a new a...

How Astellas Reset Research Procurement from 200 to 10 Suppliers

26 Jul 2025

Contributed by Lukas

“From Tokyo to Boston, we knew people had to see and feel the future we were building together. That is how you create lasting change.”Amber Meriw...

From Film to Pharma: Inside FUJIFILM Biotechnologies' $5 Billion Growth Strategy

23 Jul 2025

Contributed by Lukas

"Current revenue scale is $1.3 billion. We anticipate it will grow to $5 billion, just in five years' time. We've committed to invest about two-thirds...

Follow the Money How Private Equity Capital Flows are Reshaping the CDMO Landscape

20 Jul 2025

Contributed by Lukas

A panel of M&A advisors and consultants at CDMO Live 2025 explored how private equity investment has transformed the contract manufacturing sector...

Biologics at Scale: Navigating Development & Manufacturing Challenges in an Uncertain World

13 Jul 2025

Contributed by Lukas

The biologics external manufacturing panel at CDMO Live 2025, sponsored by BSP Pharmaceuticals, brought together industry leaders to tackle the key ch...

Gene Therapy at a Crossroads: Novartis Leader Maps the Journey From Hype to Reality

13 Jul 2025

Contributed by Lukas

Joshi Venugopal, SVP and Head of Region for Novartis Gene Therapies, outlined three critical inflection points that will determine whether cell and ge...

European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality

06 Jul 2025

Contributed by Lukas

At CDMO Live 2025, industry leaders Elisabeth Stampa (Medicines for Europe), Elena Barboni (Flamma) and Agneta Larhed (RegSmart Life Science) discusse...

How To Build Biotechs from First Principles: Deep Science Ventures’ Formula for Science-based Innovation

25 Jun 2025

Contributed by Lukas

“When you’re building something at the edge of science, it’s crucial to start with the problem, not the solution. My team has created 15 pharma ...

10 Things I’d Do Differently When Fast Tracking Emergency Drug Manufacturing

22 Jun 2025

Contributed by Lukas

The COVID-19 pandemic demonstrated how pharmaceutical manufacturing timelines can be dramatically compressed while maintaining quality. At CDMO Live 2...

Six Strategic Imperatives for CDMO-Sponsor Success: Simon Kucher Reveals Critical 2025 Industry Roadmap

17 Jun 2025

Contributed by Lukas

Simon Kucher opened CDMO Live 2025 in Rotterdam by unveiling brand new research developed in partnership with PharmaSource.The comprehensive study, ...

Quality as Catalyst: How Risk Culture and Transparency Drive CDMO Success

15 Jun 2025

Contributed by Lukas

CDMO Live 2025, a panel sponsored by Lifecore Biomedical brought together industry quality leaders to discuss how quality management can become a stra...

Axplora Strategy Teardown: Investing in High-Growth Therapeutics with a Customer-Driven Approach

11 Jun 2025

Contributed by Lukas

“We invest to meet the needs of the customer. What’s driving these investments are really the customer partnerships that we’re building to make ...

Digital Manufacturing Networks in the Real World

08 Jun 2025

Contributed by Lukas

At CDMO Live 2025, a panel sponsored by Aizon explored how pharma companies are transforming external manufacturing operations through digital integra...

Pharma Supply Chain Disruptions: Rx-360’s Ryan Kelly Shares Critical Best Practices

05 Jun 2025

Contributed by Lukas

“Know your supply chain. Make sure you have it well mapped. The biggest thing that we’ve seen coming out of COVID was investments in technology –...

Inside CellProthera's Strategic SEQENS Partnership: Scaling Cell Therapy from Lab to Commercial Reality

02 Jun 2025

Contributed by Lukas

"There are not that many European CDMOs with commercial expertise in cell therapy - who understand the regulatory requirements and production cha...

Building Better CDMO Relationships: ten23 health’s Blueprint for Successful Pharmaceutical Partnerships

29 May 2025

Contributed by Lukas

“My ambition for being a CDMO is that there will always be technical challenges, but I want to be transparent about the challenge and provide option...

Pharma Sustainability Focus: Science-Based Targets Now Essential

25 May 2025

Contributed by Lukas

Leaders from the Pharmaceutical Supply Chain Initiative (PSCI) and Manufacture 2030 outlined the mounting pressure on contract manufacturers to addres...

How Sandoz Navigates Uncertainty with 400+ External Manufacturing Partners

22 May 2025

Contributed by Lukas

“Nobody knows exactly what will happen, so making yourself anxious about unknowns doesn’t help. You must be prepared for multiple scenarios, ready...

Pharma's New Manufacturing Playbook for Turbulent Times

18 May 2025

Contributed by Lukas

CDMO Live 2025 Highlights: How Bayer, Boehringer Ingelheim, and Leo Pharma are rebuilding manufacturing strategiesComplexity Challenge: With thousands...

Trump 2.0 and Drug Manufacturing: "Nobody Knows Anything" - Gil Roth at CDMO Live 2025

14 May 2025

Contributed by Lukas

Gil Roth, president of the Pharma and Biopharma Outsourcing Association (PBOA), delivered a stark assessment of the uncertain regulatory and trade env...

Building Resilience in Life Sciences with Beth Benatti Kennedy: Preventing Burnout in High-Stakes Drug Development

12 May 2025

Contributed by Lukas

“Over 90% of people you meet in life sciences are going to be dealing with failure every day. You have to normalize failure in this industry to get ...

Beyond Auditing: How Qualifyze Proactively Manages Risk in Uncertain Times

07 May 2025

Contributed by Lukas

“The pharmaceutical industry is very good at being reactive. If something happens, they have very clear processes, but they’re not so good anticip...

Valneva External Manufacturing: Balancing Risk-Taking with Quality in Vaccine Development

27 Apr 2025

Contributed by Lukas

“In Big Pharma, innovation is often stifled because the bureaucracy and mindset completely kills creativity and intuition needed for discovery. That...

How Almac’s Trust Ownership Enables CDMO Success - interview with Franciane Chevot

23 Apr 2025

Contributed by Lukas

“We are privately owned by a Trust, which means all our profits are reinvested in the company. This translates to steady growth – maybe slower com...

Private Equity and Digital Maturity in the CDMO Sector - Vishnu Dwadasi, West Monroe

21 Apr 2025

Contributed by Lukas

“AI doesn’t have to be the first port of call. Many organisations still need to focus on the paper-to-glass journey before they can think about mo...

BioDuro: Building Strategic Partnerships Through Integrated CRDMO Services

20 Apr 2025

Contributed by Lukas

“Our goal is to be more than a service provider. We aim to be a strategic partner that grows with our clients from bench to bedside.” – Dr. Jim...

Animal Health Manufacturing: Boehringer Ingelheim’s Six Strategic Approaches to External Manufacturing Networks

17 Apr 2025

Contributed by Lukas

“Managing hundreds of products across multiple species requires a different approach to network strategy than human pharma,” explains Bernhard Boe...

The launch of a new CDMO: Meribel Pharma Solutions - interview with CEO Bruce Vielle

15 Apr 2025

Contributed by Lukas

Exclusive interview for PharmaSource ahead of CDMO Live“We’ve combined these two solid legacies into a new, agile CDMO with a unique focus on high...

How Afton Scientific’s Quality-First Approach Fuels Its $200 Million Expansion

12 Apr 2025

Contributed by Lukas

“Trust is what your customers need most. They take a great risk when they sign up with you to make their product. They need access within your organ...

German Biotech Days: Trump’s Biotech Dismantling Creates Talent Opportunity for European Life Sciences - Dr. Oliver Schacht

11 Apr 2025

Contributed by Lukas

“What we’re witnessing is the rapid dismantling of the US research infrastructure… It’s also an opportunity for us here in Europe to step up”...

From Family Business to Global CDMO: Bluejet Healthcare's Journey

08 Apr 2025

Contributed by Lukas

In the latest episode, we speak to  Payal Gandhi, Management Executive – Business Growth at Blue Jet Healthcare explains how the company transforma...

Novartis Gene Therapy: 5 Essential Strategies from SVP Joshi Venugopal

04 Apr 2025

Contributed by Lukas

“Europe has roughly double the population of the United States but lower pricing, so it’s a balancing act between how much volume can you get and ...

How Fisiopharma Delivers Excellence as an Injectable Pharmaceutical CDMO

01 Apr 2025

Contributed by Lukas

“Being unique or special in something is crucial, a key factor in order to gain success in this field.” – Angela MolaschiAngela Molaschi, Chief...

Pharma Digital Transformation - Interview with Dr. Franziskus Kath

29 Mar 2025

Contributed by Lukas

"Digital transformation is not about technology deployment. It's about a new way of doing business that allows you to make jumps which were n...

Bold capacity investments lag despite urgent need for decentralised pharma supply chains - Roland Berger

24 Mar 2025

Contributed by Lukas

“What we’re witnessing is a fundamental shift from globalized to decentralized pharma supply chains, yet many companies are hesitant to make the b...

CDMO Cultural Alignment: Why the Disney effect is killing partnerships with John Philips

21 Mar 2025

Contributed by Lukas

“Every CDMO is going to give you the Disney effect. I want to see what’s below the street. How is that organisation humming below the surface?” ...

Recipharm’s CDMO Evolution: Technology Investment Powering Global Growth

19 Mar 2025

Contributed by Lukas

“Every minute, over 1000 patients are using a product manufactured in one of our sites,” reveals Kerstin Vieluf, Head of Sales at Recipharm.Headq...

Quality Excellence at UCB: Liesbeth Foesters on Leadership in External Manufacturing

16 Mar 2025

Contributed by Lukas

“I believe that if a quality culture is really embedded, the quality organisation starts reducing, because the more quality is embedded in the organ...

Digital Marketing in Pharma: Sciential's Maurice van Rotterdam Shares His Playbook

12 Mar 2025

Contributed by Lukas

Maurice van Rotterdam, Co-Founder of Netherlands-based digital marketing agency Sciential, believes many pharma suppliers and CDMOs are still missing ...